Home › Funds › Casdin Capital › LAB
Casdin Capital position in LAB
STANDARD BIOTOOLS INC · Industrials
Latest position (Q2 2026)88.78M sh
Reported value held$73.04M
Portfolio Weight3.66%
First reportedQ2 2023
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2023 | 1.20M | $2.32M | New |
| Q3 2023 | 1.20M | $3.48M | Hold |
| Q4 2023 | 1.20M | $2.65M | Hold |
| Q1 2024 | 61.91M | $167.77M | Add |
| Q2 2024 | 63.96M | $113.21M | Add |
| Q3 2024 | 71.25M | $137.52M | Add |
| Q4 2024 | 71.25M | $124.70M | Hold |
| Q1 2025 | 76.08M | $82.16M | Add |
| Q2 2025 | 76.08M | $91.29M | Hold |
| Q3 2025 | 77.56M | $100.83M | Add |
| Q4 2025 | 88.78M | $113.64M | Add |
| Q1 2026 | 88.78M | $81.62M | Hold |
| Q2 2026 | 88.78M | $73.04M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LAB
- Viking Global Investors 58.65M sh · $48.25M · Q2 2026
- Vanguard Group 17.30M sh · $22.14M · Q4 2025
- BlackRock Inc 8.25M sh · $6.79M · Q2 2026
- Royce & Associates 4.53M sh · $3.72M · Q2 2026
- Geode Capital Management 3.90M sh · $3.21M · Q2 2026
- Millennium Management 3.51M sh · $2.89M · Q2 2026
- Morgan Stanley 2.83M sh · $2.33M · Q2 2026
- D. E. Shaw & Co 2.82M sh · $2.32M · Q2 2026
- Arrowstreet Capital 1.99M sh · $1.64M · Q2 2026
- Charles Schwab Investment Management 1.76M sh · $1.45M · Q2 2026
- AQR Capital Management 1.36M sh · $1.12M · Q2 2026